Log in to save to my catalogue

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3198067

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

About this item

Full title

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

Publisher

United States: American Diabetes Association

Journal title

Diabetes (New York, N.Y.), 2011-11, Vol.60 (11), p.3055-3066

Language

English

Formats

Publication information

Publisher

United States: American Diabetes Association

More information

Scope and Contents

Contents

To determine whether dietary compounds targeting NFE2-related factor 2 (Nrf2) activation can be used to attenuate renal damage and preserve renal function during the course of streptozotocin (STZ)-induced diabetic nephropathy.
Diabetes was induced in Nrf2(+/+) and Nrf2(-/-) mice by STZ injection. Sulforaphane (SF) or cinnamic aldehyde (CA) was a...

Alternative Titles

Full title

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3198067

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3198067

Other Identifiers

ISSN

0012-1797

E-ISSN

1939-327X

DOI

10.2337/db11-0807

How to access this item